{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:50:45Z","timestamp":1779346245345,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70491-3","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:04:23Z","timestamp":1775743463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complete inhibition of \u03b2-tryptase by tetramer dissociation and active site allostery due to a single antibody residue"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-6061","authenticated-orcid":false,"given":"Henry R.","family":"Maun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3484-9921","authenticated-orcid":false,"given":"Caleigh M.","family":"Azumaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-0696","authenticated-orcid":false,"given":"Benjamin T.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Vij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6659-0777","authenticated-orcid":false,"given":"Ashley","family":"Morando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3733-099X","authenticated-orcid":false,"given":"Kelly M.","family":"Loyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7756-972X","authenticated-orcid":false,"given":"James T.","family":"Koerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-9621","authenticated-orcid":false,"given":"Alexis","family":"Rohou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5538-5230","authenticated-orcid":false,"given":"Robert A.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"70491_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri3690","volume":"14","author":"S Wernersson","year":"2014","unstructured":"Wernersson, S. & Pejler, G. Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 14, 478\u2013494 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"70491_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","volume":"39","author":"F Siebenhaar","year":"2018","unstructured":"Siebenhaar, F., Redegeld, F. A., Bischoff, S. C., Gibbs, B. F. & Maurer, M. Mast cells as drivers of disease and therapeutic targets. Trends Immunol. 39, 151\u2013162 (2018).","journal-title":"Trends Immunol."},{"key":"70491_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.it.2017.04.001","volume":"38","author":"B Frossi","year":"2017","unstructured":"Frossi, B., Mion, F., Tripodo, C., Colombo, M. P. & Pucillo, C. E. Rheostatic functions of mast cells in the control of innate and adaptive immune responses. Trends Immunol. 38, 648\u2013656 (2017).","journal-title":"Trends Immunol."},{"key":"70491_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2015.04.045","volume":"778","author":"GH Caughey","year":"2016","unstructured":"Caughey, G. H. Mast cell proteases as pharmacological targets. Eur. J. Pharm. 778, 44\u201355 (2016).","journal-title":"Eur. J. Pharm."},{"key":"70491_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0065-2776(07)95006-3","volume":"95","author":"G Pejler","year":"2007","unstructured":"Pejler, G., Abrink, M., Ringvall, M. & Wernersson, S. Mast cell proteases. Adv. Immunol. 95, 167\u2013255 (2007).","journal-title":"Adv. Immunol."},{"key":"70491_CR6","doi-asserted-by":"crossref","unstructured":"Pejler, G. The emerging role of mast cell proteases in asthma. Eur. Respir. J. 54, 1900685 (2019).","DOI":"10.1183\/13993003.00685-2019"},{"key":"70491_CR7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1152\/jappl.2001.91.3.1372","volume":"91","author":"P Berger","year":"2001","unstructured":"Berger, P. et al. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J. Appl Physiol. 91, 1372\u20131379 (2001).","journal-title":"J. Appl Physiol."},{"key":"70491_CR8","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1172\/JCI119290","volume":"99","author":"JA Cairns","year":"1997","unstructured":"Cairns, J. A. & Walls, A. F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest 99, 1313\u20131321 (1997).","journal-title":"J. Clin. Invest"},{"key":"70491_CR9","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.4049\/jimmunol.181.7.5001","volume":"181","author":"L Woodman","year":"2008","unstructured":"Woodman, L. et al. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-\u03b21. J. Immunol. 181, 5001\u20135007 (2008).","journal-title":"J. Immunol."},{"key":"70491_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","volume":"179","author":"HR Maun","year":"2019","unstructured":"Maun, H. R. et al. An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma. Cell 179, 417\u2013431.e419 (2019).","journal-title":"Cell"},{"key":"70491_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pupt.2004.09.032","volume":"18","author":"JA Cairns","year":"2005","unstructured":"Cairns, J. A. Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders. Pulm. Pharm. Ther. 18, 55\u201366 (2005).","journal-title":"Pulm. Pharm. Ther."},{"key":"70491_CR12","doi-asserted-by":"publisher","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","volume":"46","author":"ND Rawlings","year":"2017","unstructured":"Rawlings, N. D. et al. The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. Nucleic Acids Res. 46, D624\u2013D632 (2017).","journal-title":"Nucleic Acids Res."},{"key":"70491_CR13","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.4049\/jimmunol.1001806","volume":"187","author":"QT Le","year":"2011","unstructured":"Le, Q. T. et al. Processing of human protryptase in mast cells involves cathepsins L, B, and C. J. Immunol. 187, 1912\u20131918 (2011).","journal-title":"J. Immunol."},{"key":"70491_CR14","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.1016\/S0021-9258(17)38401-6","volume":"261","author":"LB Schwartz","year":"1986","unstructured":"Schwartz, L. B. & Bradford, T. R. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J. Biol. Chem. 261, 7372\u20137379 (1986).","journal-title":"J. Biol. Chem."},{"key":"70491_CR15","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1021\/bi960042t","volume":"35","author":"AK Addington","year":"1996","unstructured":"Addington, A. K. & Johnson, D. A. Inactivation of human lung tryptase: Evidence for a re-activatable tetrameric intermediate and active monomers. Biochemistry 35, 13511\u201313518 (1996).","journal-title":"Biochemistry"},{"key":"70491_CR16","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.4049\/jimmunol.160.9.4561","volume":"160","author":"S Ren","year":"1998","unstructured":"Ren, S., Sakai, K. & Schwartz, L. B. Regulation of human mast cell \u03b2-tryptase: Conversion of inactive monomer to active tetramer at acid pH. J. Immunol. 160, 4561\u20134569 (1998).","journal-title":"J. Immunol."},{"key":"70491_CR17","doi-asserted-by":"publisher","first-page":"9615","DOI":"10.1021\/bi7004625","volume":"46","author":"NM Schechter","year":"2007","unstructured":"Schechter, N. M., Choi, E. J., Selwood, T. & McCaslin, D. R. Characterization of three distinct catalytic forms of human tryptase-\u03b2: their interrelationships and relevance. Biochemistry 46, 9615\u20139629 (2007).","journal-title":"Biochemistry"},{"key":"70491_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jmb.2004.10.029","volume":"345","author":"J Hallgren","year":"2005","unstructured":"Hallgren, J., Lindahl, S. & Pejler, G. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human \u03b2I- and \u03b2II-tryptase. J. Mol. Biol. 345, 129\u2013139 (2005).","journal-title":"J. Mol. Biol."},{"key":"70491_CR19","doi-asserted-by":"publisher","first-page":"9614","DOI":"10.1074\/jbc.M117.812016","volume":"293","author":"HR Maun","year":"2018","unstructured":"Maun, H. R. et al. Dual functionality of \u03b2-tryptase protomers as both proteases and cofactors in the active tetramer. J. Biol. Chem. 293, 9614\u20139628 (2018).","journal-title":"J. Biol. Chem."},{"key":"70491_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/bj20021418","volume":"369","author":"I Fajardo","year":"2003","unstructured":"Fajardo, I. & Pejler, G. Formation of active monomers from tetrameric human \u03b2-tryptase. Biochem J. 369, 603\u2013610 (2003).","journal-title":"Biochem J."},{"key":"70491_CR21","doi-asserted-by":"publisher","first-page":"10757","DOI":"10.1021\/bi049486c","volume":"43","author":"Y Fukuoka","year":"2004","unstructured":"Fukuoka, Y. & Schwartz, L. B. Human \u03b2-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry 43, 10757\u201310764 (2004).","journal-title":"Biochemistry"},{"key":"70491_CR22","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.intimp.2007.07.007","volume":"7","author":"Y Fukuoka","year":"2007","unstructured":"Fukuoka, Y. & Schwartz, L. B. Active monomers of human \u03b2-tryptase have expanded substrate specificities. Int. Immunopharmacol. 7, 1900\u20131908 (2007).","journal-title":"Int. Immunopharmacol."},{"key":"70491_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0022-3565(25)24170-2","volume":"248","author":"GM Franconi","year":"1989","unstructured":"Franconi, G. M., Graf, P. D., Lazarus, S. C., Nadel, J. A. & Caughey, G. H. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret. J. Pharm. Exp. Ther. 248, 947\u2013951 (1989).","journal-title":"J. Pharm. Exp. Ther."},{"key":"70491_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI114344","volume":"84","author":"BL Gruber","year":"1989","unstructured":"Gruber, B. L. et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest 84, 1657\u20131662 (1989).","journal-title":"J. Clin. Invest"},{"key":"70491_CR25","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.4049\/jimmunol.130.5.2352","volume":"130","author":"M Maier","year":"1983","unstructured":"Maier, M., Spragg, J. & Schwartz, L. B. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J. Immunol. 130, 2352\u20132356 (1983).","journal-title":"J. Immunol."},{"key":"70491_CR26","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.4049\/jimmunol.0803587","volume":"183","author":"F Schiemann","year":"2009","unstructured":"Schiemann, F. et al. The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4. J. Immunol. 183, 2223\u20132231 (2009).","journal-title":"J. Immunol."},{"key":"70491_CR27","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.4049\/jimmunol.135.4.2762","volume":"135","author":"LB Schwartz","year":"1985","unstructured":"Schwartz, L. B., Bradford, T. R., Littman, B. H. & Wintroub, B. U. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 135, 2762\u20132767 (1985).","journal-title":"J. Immunol."},{"key":"70491_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/32703","volume":"392","author":"PJ Pereira","year":"1998","unstructured":"Pereira, P. J. et al. Human \u03b2-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392, 306\u2013311 (1998).","journal-title":"Nature"},{"key":"70491_CR29","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.1073\/pnas.96.20.10984","volume":"96","author":"CP Sommerhoff","year":"1999","unstructured":"Sommerhoff, C. P. et al. The structure of the human \u03b2II-tryptase tetramer: Fo(u)r better or worse. Proc. Natl. Acad. Sci. USA 96, 10984\u201310991 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70491_CR30","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.4049\/jimmunol.173.3.1868","volume":"173","author":"J Hallgren","year":"2004","unstructured":"Hallgren, J., Backstrom, S., Estrada, S., Thuveson, M. & Pejler, G. Histidines are critical for heparin-dependent activation of mast cell tryptase. J. Immunol. 173, 1868\u20131875 (2004).","journal-title":"J. Immunol."},{"key":"70491_CR31","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.4049\/jimmunol.176.5.3165","volume":"176","author":"Y Fukuoka","year":"2006","unstructured":"Fukuoka, Y. & Schwartz, L. B. The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized \u03b2-tryptase to form monomers that are inactive at neutral pH and active at acidic pH. J. Immunol. 176, 3165\u20133172 (2006).","journal-title":"J. Immunol."},{"key":"70491_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0003-9861(90)90005-J","volume":"276","author":"SC Alter","year":"1990","unstructured":"Alter, S. C., Kramps, J. A., Janoff, A. & Schwartz, L. B. Interactions of human mast cell tryptase with biological protease inhibitors. Arch. Biochem Biophys. 276, 26\u201331 (1990).","journal-title":"Arch. Biochem Biophys."},{"key":"70491_CR33","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.jmb.2007.03.011","volume":"368","author":"GC Paesen","year":"2007","unstructured":"Paesen, G. C. et al. A tick protein with a modified Kunitz fold inhibits human tryptase. J. Mol. Biol. 368, 1172\u20131186 (2007).","journal-title":"J. Mol. Biol."},{"key":"70491_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1515\/bchm3.1994.375.10.685","volume":"375","author":"CP Sommerhoff","year":"1994","unstructured":"Sommerhoff, C. P. et al. A Kazal-type inhibitor of human mast cell tryptase: Isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. Biol. Chem. Hoppe Seyler 375, 685\u2013694 (1994).","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"70491_CR35","doi-asserted-by":"publisher","first-page":"19931","DOI":"10.1074\/jbc.272.32.19931","volume":"272","author":"MT Stubbs","year":"1997","unstructured":"Stubbs, M. T. et al. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J. Biol. Chem. 272, 19931\u201319937 (1997).","journal-title":"J. Biol. Chem."},{"key":"70491_CR36","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1021\/jm4005362","volume":"56","author":"S Rothemund","year":"2013","unstructured":"Rothemund, S., Sonnichsen, F. D. & Polte, T. Therapeutic potential of the peptide leucine arginine as a new nonplant Bowman-Birk-like serine protease inhibitor. J. Med Chem. 56, 6732\u20136744 (2013).","journal-title":"J. Med Chem."},{"key":"70491_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1021\/np010304e","volume":"65","author":"Y Murakami","year":"2002","unstructured":"Murakami, Y. et al. Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge. J. Nat. Prod. 65, 259\u2013261 (2002).","journal-title":"J. Nat. Prod."},{"key":"70491_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cbic.200700452","volume":"9","author":"O Avrutina","year":"2008","unstructured":"Avrutina, O. et al. Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis. Chembiochem 9, 33\u201337 (2008).","journal-title":"Chembiochem"},{"key":"70491_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmb.2009.10.028","volume":"395","author":"CP Sommerhoff","year":"2010","unstructured":"Sommerhoff, C. P. et al. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase \u03b2. J. Mol. Biol. 395, 167\u2013175 (2010).","journal-title":"J. Mol. Biol."},{"key":"70491_CR40","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1021\/jm901233u","volume":"52","author":"P Thongyoo","year":"2009","unstructured":"Thongyoo, P., Bonomelli, C., Leatherbarrow, R. J. & Tate, E. W. Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J. Med Chem. 52, 6197\u20136200 (2009).","journal-title":"J. Med Chem."},{"key":"70491_CR41","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1016\/j.bmc.2004.09.015","volume":"12","author":"D Scarpi","year":"2004","unstructured":"Scarpi, D., McBride, J. D. & Leatherbarrow, R. J. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor. Bioorg. Med Chem. 12, 6045\u20136052 (2004).","journal-title":"Bioorg. Med Chem."},{"key":"70491_CR42","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.1021\/bi060173m","volume":"45","author":"ME McGrath","year":"2006","unstructured":"McGrath, M. E. et al. Structure-guided design of peptide-based tryptase inhibitors. Biochemistry 45, 5964\u20135973 (2006).","journal-title":"Biochemistry"},{"key":"70491_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/13543776.2017.1322064","volume":"27","author":"WW Ni","year":"2017","unstructured":"Ni, W. W., Cao, M. D., Huang, W., Meng, L. & Wei, J. F. Tryptase inhibitors: a patent review. Expert Opin. Ther. Pat. 27, 919\u2013928 (2017).","journal-title":"Expert Opin. Ther. Pat."},{"key":"70491_CR44","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1021\/jo010757o","volume":"67","author":"X Qian","year":"2002","unstructured":"Qian, X., Zheng, B., Burke, B., Saindane, M. T. & Kronenthal, D. R. A stereoselective synthesis of BMS-262084, an azetidinone-based tryptase inhibitor. J. Org. Chem. 67, 3595\u20133600 (2002).","journal-title":"J. Org. Chem."},{"key":"70491_CR45","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1016\/S0960-894X(02)00688-1","volume":"12","author":"JC Sutton","year":"2002","unstructured":"Sutton, J. C. et al. Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorg. Med Chem. Lett. 12, 3229\u20133233 (2002).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"70491_CR46","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0006-2952(99)00304-4","volume":"58","author":"CD Wright","year":"1999","unstructured":"Wright, C. D. et al. Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-[4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy]-pen tane (AMG-126737). Biochem Pharm. 58, 1989\u20131996 (1999).","journal-title":"Biochem Pharm."},{"key":"70491_CR47","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.bmcl.2008.01.093","volume":"18","author":"MJ Costanzo","year":"2008","unstructured":"Costanzo, M. J. et al. Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of new spirocyclic piperidine amide derivatives. Bioorg. Med Chem. Lett. 18, 2114\u20132121 (2008).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"70491_CR48","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1067\/mai.2001.115631","volume":"107","author":"MT Krishna","year":"2001","unstructured":"Krishna, M. T. et al. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J. Allergy Clin. Immunol. 107, 1039\u20131045 (2001).","journal-title":"J. Allergy Clin. Immunol."},{"key":"70491_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20100634","volume":"430","author":"R Ganesan","year":"2010","unstructured":"Ganesan, R., Eigenbrot, C. & Kirchhofer, D. Structural and mechanistic insight into how antibodies inhibit serine proteases. Biochem J. 430, 179\u2013189 (2010).","journal-title":"Biochem J."},{"key":"70491_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20143-x","volume":"11","author":"HR Maun","year":"2020","unstructured":"Maun, H. R. et al. Bivalent antibody pliers inhibit beta-tryptase by an allosteric mechanism dependent on the IgG hinge. Nat. Commun. 11, 6435 (2020).","journal-title":"Nat. Commun."},{"key":"70491_CR51","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1111\/all.16309","volume":"79","author":"H Rhee","year":"2024","unstructured":"Rhee, H. et al. Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma. Allergy 79, 2993\u20133004 (2024).","journal-title":"Allergy"},{"key":"70491_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1098\/rstb.1970.0010","volume":"257","author":"BS Hartley","year":"1970","unstructured":"Hartley, B. S. Homologies in serine proteinases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 257, 77\u201387 (1970).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"70491_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jmb.2017.12.010","volume":"430","author":"J Ereno-Orbea","year":"2018","unstructured":"Ereno-Orbea, J. et al. Structural basis of enhanced crystallizability induced by a molecular chaperone for antibody antigen-binding fragments. J. Mol. Biol. 430, 322\u2013336 (2018).","journal-title":"J. Mol. Biol."},{"key":"70491_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/ar50123a006","volume":"11","author":"R Huber","year":"1978","unstructured":"Huber, R. & Bode, W. Structural basis of the activation and action of trypsin. Acc. Chem. Res 11, 114\u2013122 (1978).","journal-title":"Acc. Chem. Res"},{"key":"70491_CR55","doi-asserted-by":"publisher","first-page":"34920","DOI":"10.1074\/jbc.M113.523506","volume":"288","author":"KM Cook","year":"2013","unstructured":"Cook, K. M., McNeil, H. P. & Hogg, P. J. Allosteric control of betaII-tryptase by a redox active disulfide bond. J. Biol. Chem. 288, 34920\u201334929 (2013).","journal-title":"J. Biol. Chem."},{"key":"70491_CR56","doi-asserted-by":"publisher","first-page":"27165","DOI":"10.1074\/jbc.M703202200","volume":"282","author":"LA Bush-Pelc","year":"2007","unstructured":"Bush-Pelc, L. A. et al. Important role of the cys-191 cys-220 disulfide bond in thrombin function and allostery. J. Biol. Chem. 282, 27165\u201327170 (2007).","journal-title":"J. Biol. Chem."},{"key":"70491_CR57","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.1073\/pnas.86.21.8319","volume":"86","author":"T Miyata","year":"1989","unstructured":"Miyata, T. et al. Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571\u2013Ser substitution. Proc. Natl. Acad. Sci. USA 86, 8319\u20138322 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70491_CR58","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.str.2009.09.014","volume":"17","author":"R Ganesan","year":"2009","unstructured":"Ganesan, R. et al. Unraveling the allosteric mechanism of serine protease inhibition by an antibody. Structure 17, 1614\u20131624 (2009).","journal-title":"Structure"},{"key":"70491_CR59","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1016\/j.jmb.2019.09.008","volume":"431","author":"M Schaefer","year":"2019","unstructured":"Schaefer, M., Buchmueller, A., Dittmer, F., Strassburger, J. & Wilmen, A. Allosteric inhibition as a new mode of action for BAY 1213790, a neutralizing antibody targeting the activated form of coagulation factor XI. J. Mol. Biol. 431, 4817\u20134833 (2019).","journal-title":"J. Mol. Biol."},{"key":"70491_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/BJ20121132","volume":"449","author":"L Jiang","year":"2013","unstructured":"Jiang, L. et al. Rezymogenation of active urokinase induced by an inhibitory antibody. Biochem J. 449, 161\u2013166 (2013).","journal-title":"Biochem J."},{"key":"70491_CR61","doi-asserted-by":"publisher","first-page":"12886","DOI":"10.1074\/jbc.M112.345082","volume":"287","author":"KJ Katschke Jr.","year":"2012","unstructured":"Katschke, K. J. Jr. et al. Inhibiting alternative pathway complement activation by targeting the factor D exosite. J. Biol. Chem. 287, 12886\u201312892 (2012).","journal-title":"J. Biol. Chem."},{"key":"70491_CR62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1042\/BJ20111317","volume":"442","author":"T Koschubs","year":"2012","unstructured":"Koschubs, T. et al. Allosteric antibody inhibition of human hepsin protease. Biochem J. 442, 483\u2013494 (2012).","journal-title":"Biochem J."},{"key":"70491_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp9159","volume":"14","author":"J Chavarria-Smith","year":"2022","unstructured":"Chavarria-Smith, J. et al. Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis. Sci. Transl. Med 14, eabp9159 (2022).","journal-title":"Sci. Transl. Med"},{"key":"70491_CR64","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1182\/blood-2009-06-225979","volume":"115","author":"E Mossner","year":"2010","unstructured":"Mossner, E. et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood 115, 4393\u20134402 (2010).","journal-title":"Blood"},{"key":"70491_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01530-w","volume":"11","author":"WC Liang","year":"2021","unstructured":"Liang, W. C. et al. Dramatic activation of an antibody by a single amino acid change in framework. Sci. Rep. 11, 22365 (2021).","journal-title":"Sci. Rep."},{"key":"70491_CR66","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.3390\/ijms20205147","volume":"20","author":"Z Fu","year":"2019","unstructured":"Fu, Z., Akula, S., Thorpe, M. & Hellman, L. Highly selective cleavage of TH2-promoting cytokines by the human and the mouse mast cell tryptases, indicating a potent negative feedback loop on TH2 immunity. Int. J. Mol. Sci. 20, 5147 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"70491_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32760-9","volume":"13","author":"S Gerhardy","year":"2022","unstructured":"Gerhardy, S. et al. Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration. Nat. Commun. 13, 5222 (2022).","journal-title":"Nat. Commun."},{"key":"70491_CR68","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s13361-012-0476-x","volume":"23","author":"BT Walters","year":"2012","unstructured":"Walters, B. T., Ricciuti, A., Mayne, L. & Englander, S. W. Minimizing back exchange in the hydrogen exchange-mass spectrometry experiment. J. Am. Soc. Mass Spectrom. 23, 2132\u20132139 (2012).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"70491_CR69","doi-asserted-by":"publisher","first-page":"7474","DOI":"10.1021\/acs.analchem.9b01682","volume":"91","author":"ZY Kan","year":"2019","unstructured":"Kan, Z. Y., Ye, X., Skinner, J. J., Mayne, L. & Englander, S. W. ExMS2: an Integrated Solution for Hydrogen-Deuterium Exchange Mass Spectrometry Data Analysis. Anal. Chem. 91, 7474\u20137481 (2019).","journal-title":"Anal. Chem."},{"key":"70491_CR70","doi-asserted-by":"publisher","first-page":"18898","DOI":"10.1073\/pnas.1319482110","volume":"110","author":"BT Walters","year":"2013","unstructured":"Walters, B. T., Mayne, L., Hinshaw, J. R., Sosnick, T. R. & Englander, S. W. Folding of a large protein at high structural resolution. Proc. Natl. Acad. Sci. USA 110, 18898\u201318903 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70491_CR71","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1021\/acs.analchem.6b03908","volume":"89","author":"BT Walters","year":"2017","unstructured":"Walters, B. T. Empirical method to accurately determine peptide-averaged protection factors from hydrogen exchange MS data. Anal. Chem. 89, 1049\u20131053 (2017).","journal-title":"Anal. Chem."},{"key":"70491_CR72","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41592-019-0459-y","volume":"16","author":"GR Masson","year":"2019","unstructured":"Masson, G. R. et al. Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments. Nat. Methods 16, 595\u2013602 (2019).","journal-title":"Nat. Methods"},{"key":"70491_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"70491_CR74","doi-asserted-by":"publisher","first-page":"D1503","DOI":"10.1093\/nar\/gkac1062","volume":"51","author":"A Iudin","year":"2023","unstructured":"Iudin, A. et al. EMPIAR: the electron microscopy public image archive. Nucleic Acids Res. 51, D1503\u2013D1511 (2023).","journal-title":"Nucleic Acids Res."},{"key":"70491_CR75","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"70491_CR76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"70491_CR77","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D. Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"70491_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"70491_CR79","unstructured":"The PyMOL Molecular Graphics System, Version 3.1.3 Schr\u00f6dinger, LLC."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70491-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:02:11Z","timestamp":1775836931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70491-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70491"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70491-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors were employees of Genentech, Inc. and shareholders of Roche stock at the time the work was done.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3393"}}